ClinicalTrials.Veeva

Menu

The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease (PR-ILD)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Completed

Conditions

Interstitial Lung Disease

Treatments

Other: Pulmonary rehabilitation

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine if pulmonary rehabilitation has any effect on breathlessness, quality of life, physical function and depression in persons with interstitial lung disease.

Enrollment

54 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (> 18 years old) with a diagnosis of ILD who are referred to a participating PR program

Exclusion criteria

  • Inability to provide informed consent
  • Inability to read and write English
  • Any other medical condition that significantly limits the subject's ability to perform the functional measures
  • Emphysema / Chronic bronchitis (FEV1 / FVC ratio < 60%)
  • Previous pulmonary rehabilitation

Trial design

54 participants in 1 patient group

Pulmonary rehabilitation
Treatment:
Other: Pulmonary rehabilitation

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems